Oncogenomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer.

Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment

    Related Conference of Oncogenomics

    January 19-20, 2026

    17th International Conference on Biofuels and Bioenergy

    Barcelona, Spain
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    July 23-24, 2026

    22nd World Congress on Structural Biology

    Aix-en-Provence, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain

    Oncogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in